Business Context and Reporting Period
This Form 8-K filing by CareDx, Inc. reports on the results of the 2017 Annual Meeting of Stockholders held on June 13, 2017. The report was filed on July 13, 2017. As of the record date (May 15, 2017), there were 21,421,016 shares of common stock outstanding, with 14,679,329 shares represented at the meeting, constituting a quorum.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders voted on three proposals, all of which were approved:
- Proposal 1 (Election of Directors): Two Class III directors were elected to serve until the 2020 annual meeting.
- Michael D. Goldberg: 7,548,202 votes for; 451,014 votes withheld.
- Peter Maag, Ph.D.: 7,515,676 votes for; 483,540 votes withheld.
- Proposal 2 (Ratification of Auditors): Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2017.
- Votes For: 14,293,728
- Votes Against: 287,272
- Abstentions: 98,329
- Proposal 3 (Debt Conversion Authorization): Stockholders approved the issuance of common stock upon the conversion or redemption of the Company's 9.5% Original Issue Discount Senior Secured Debentures due February 28, 2020. This approval removes the need for a limitation or cap on issuances required by NASDAQ Listing Rule 5635.
- Votes For: 7,965,731
- Votes Against: 33,485
- Abstentions: 0
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting process. The approval of Proposal 3 indicates a strategic move to facilitate potential equity issuance related to existing senior secured debt.
Key Facts for Investor Verification
- Verify the terms of the 9.5% Original Issue Discount Senior Secured Debentures due February 28, 2020, to understand the potential dilution impact from the approved conversion mechanism.
- Confirm the composition of the Board of Directors following the election of Michael D. Goldberg and Peter Maag, Ph.D.
- Review the definitive proxy statement filed on May 30, 2017, for detailed background on the proposals and director nominees.